InternationalUSRemember you can easily switch between MIP US and MIP International at any time

USPTO, AbbVie, Amgen, ITC, design patents – the week in IP

Michael Loney

Recent intellectual property news included a proposal to make the USPTO an independent agency, a record year for US patent issuance, a settlement of AbbVie and Amgen’s Humira biosimilar dispute, a surge of complaints at the International Trade Commission, and the first post-Samsung verdict on design patent damages

Recent intellectual property news included

Federal Circuit issues narrow en banc Aqua Products opinion

PTAB filling falls in Q3 but still on track for record year

Data: ED of Texas’s post-TC Heartland share of US patent cases falls to 16%...

Please log in to read the rest of this article. 

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It's free to join and the benefits start straight away.

Sign up for a free trial today. 

Popular Posts

Blog Archive

IP-related blogs

1709 Copyright Blog


AIA blog

Art and Artifice

China IPR

Class 99

Domain Incite

FOSS Patents

Green Patent Blog


IP CloseUp

IP Dragon

IP finance

IP Kat

IP Komodo

IP tango

IP Watchdog


MARQUES Class 46

Orange Book Blog

Patent Baristas



SPC Blog

Spicy IP

The Trademark Blog

The TTABlog